PRESS RELEASE published on 08/04/2023 at 16:30, 1 year 3 months ago Iute Group EUR 2021/2026 bondholders with great consent to amend terms and conditions – Bondholders’ Meeting secures greater financial flexibility for growth
PRESS RELEASE published on 07/13/2023 at 11:30, 1 year 4 months ago Iute initiates process to amend terms and conditions of EUR 2021/2026 bonds – Invitation to Bondholders’ Meeting on 3 August 2023
PRESS RELEASE published on 07/12/2023 at 14:00, 1 year 4 months ago Iute announces settlement and listing of EUR 10 million tap on EUR 2021/2026 bonds Total volume of bonds outstanding EUR 125 million
PRESS RELEASE published on 07/05/2023 at 15:00, 1 year 4 months ago Iute places EUR 10 million tap on EUR 2021/2026 bonds in connection with exchange offer for EUR 2019/2023 bonds – Total volume of bonds outstanding EUR 125 million
PRESS RELEASE published on 05/30/2023 at 16:20, 1 year 5 months ago Iute after continued interest from investors with renewed exchange offer for EUR bond 2019/2023 – Tap of EUR Bond 2021/2026 by up to EUR 10 million
PRESS RELEASE published on 05/29/2023 at 07:30, 1 year 5 months ago Iute Group reports unaudited results for 3M/2023 – Quality over quantity for financial year 2023
PRESS RELEASE published on 05/11/2023 at 09:00, 1 year 6 months ago Iute Group reports unaudited 3M 2023 results on 29 May 2023 – Invitation to earnings webcast/call on 30 May 2023
PRESS RELEASE published on 04/06/2023 at 17:00, 1 year 7 months ago Iute announces settlement and listing of EUR 40 million tap on EUR 2021/2026 bonds - Total volume of bonds outstanding EUR 115 million
PRESS RELEASE published on 03/31/2023 at 18:00, 1 year 7 months ago Iute places EUR 40 million tap on EUR 2021/2026 bonds – Strong appetite from existing investors boosted by new subscriptions
PRESS RELEASE published on 03/30/2023 at 07:30, 1 year 7 months ago Iute with strong Appetite from existing investors for EUR 2021/2026 bonds exchange offer – Public Offer for EUR 2021/2026 Bonds continues until 31 March 2023
Published on 11/21/2024 at 10:03, 55 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 58 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 58 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 23 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 33 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 28 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 53 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 56 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 58 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 58 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 4 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 38 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 13 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 13 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
